Developer docs
API playgroundTry for free, no card

Search company profiles

FASMAC

Full company profile

uuid000kppk

Namestring
FASMAC
Legal namestring
株式会社ファスマック
Websiteurl
fasmac.co.jp
Company typeenum
Private
Founded yearint
2001
Descriptiontext

FASMAC Co., Ltd. (株式会社ファスマック) is a Japanese biotechnology company founded in 2001 and headquartered in Atsugi, Japan, providing contract molecular biology services and food safety testing. The company operates a vertically integrated service platform spanning custom oligonucleotide and gene synthesis, PNA synthesis, Sanger capillary sequencing, next-generation sequencing (via both Illumina and MGI DNB-SEQ platforms), CRISPR/Cas-based genome editing tools, and a proprietary random integration analysis method called RAISING. On the testing side, FASMAC offers food inspection (GMO, allergen, microbial, mycotoxin, and variety identification), seed and seedling testing under ISTA accreditation, plant pathology diagnostics, and veterinary diagnostics, all delivered through an ISO/IEC 17025-accredited testing laboratory operating under an ISO9001-certified quality management system.

FASMAC's technology stack combines in-house developed proprietary assets with licensed IP. The patented RAISING method, co-developed with Japan's National Institute of Infectious Diseases and published in Communications Biology, enables identification of random transgene integration sites with high sensitivity, short turnaround, and lower cost than conventional approaches. The company holds an ERS Genomics-licensed CRISPR/Cas patent portfolio (Patents 6343605 and 6692856) covering Japan and operates the GenomeCraft sub-brand for sgRNA, crRNA/tracrRNA, Cas9 protein, and donor DNA. In-house reagent kit brands include GenCheck (DNA extraction and qPCR reagents), FLight (LAMP isothermal amplification detection), FASPEK (ELISA allergen detection), and AGripalette (plant pathogen detection). Quality and accreditation infrastructure — ISO9001, ISO/IEC 17025, and ISTA — underwrite the regulatory credibility of testing services.

Commercially, FASMAC generates revenue through commissioned service fees (e.g., RAISING Sanger sequencing at 120,000 JPY per 8 samples; NGS at 250,000 JPY per 8 samples), reagent kit sales, and licensing-related distribution. Distribution combines a self-serve web ordering platform (Fasmac Web System) with a regional distributor/agency network across Japanese prefectures. Customers span three primary verticals: food industry companies requiring safety and labeling compliance, life science research institutions and biotech firms needing custom oligos, sequencing, and genome editing tools, and seed and agricultural companies requiring ISTA-certified seed testing and plant pathology diagnostics. The company has a minority-held food testing subsidiary in Qingdao, China, and an affiliated Asia Food Safety Research Center, and has announced a planned facility relocation for spring 2027 or later to support continued expansion. No revenue, funding, or headcount-growth data is publicly disclosed.

Short descriptiontext

FASMAC is a Japanese biotechnology company providing custom DNA/RNA synthesis, Sanger and next-generation sequencing, CRISPR genome editing tools, and ISO/IEC 17025-accredited food, seed, and plant-pathology testing services to food manufacturers, life science researchers, and seed/agricultural companies primarily in Japan.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAtsugi, Japan
HQ citystring
Atsugi
HQ countrystring
Japan
HQ regionstring
Asia
Markets served

Serves global market

Keyword5 values
DNA sequencing services, oligonucleotide synthesis, food safety testing, genome editing tools, GMO detection reagents
Industry3 codes
1Environmental Monitoring Program (EMP) Design & Regulatory Verification
CodeAFALADAIPrimaryYes
2Genomic Testing & Genetic Evaluation Services
CodeAFAEAJACPrimaryNo
3Import/Export Traceability & Trade Compliance Verification (FSMA, EU TRACES)
CodeAFALAGAIPrimaryNo
NAICS code1 code
  • Scientific Research and Development Services5417
SIC code2 codes
  • Services-Testing Laboratories8734
  • Services-Commercial Physical & Biological Research8731
Product category
Biotechnology Contract Services
Social media profiles1 record
Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
Pricing details2 tiers
1RAISING Sanger Sequencing Plan — 8 samples, 5-10 business days
ModelUnit PricingBilling cadencePay-as-you-go
Notes

120,000 JPY for 8 samples (approximately 15,000 JPY per sample). Includes waveform data (ab1 file) and sequence data (txt file). Read length: 600-700 bp. Turnaround: 5-10 business days.

fasmac.co.jp
2RAISING NGS Plan — 8 samples, 20 business days
ModelUnit PricingBilling cadencePay-as-you-go
Notes

250,000 JPY for 8 samples (approximately 31,250 JPY per sample). Includes quality-value annotated MiSeq i100 Plus output sequences (fastq file). Turnaround: 20 business days. Optional: reference mapping for insertion position determination (+20,000 JPY per target) and annotation information (+20,000 JPY per target).

fasmac.co.jp
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 5 records shown
1GenCheck
Description

DNA extraction and PCR kits brand

fasmac.co.jp
+4 more records
Core offering1 text field

FASMAC provides custom DNA/RNA and artificial gene synthesis, Sanger and next-generation sequencing, CRISPR/Cas genome editing tools (GenomeCraft), and the proprietary RAISING random integration analysis method. It also runs ISO/IEC 17025 accredited contract testing for food safety (GMO, allergen, microbial, mycotoxin), seed/seedling pathology, and plant disease, and sells proprietary reagent kits under the GenCheck, FLight, FASPEK, and AgriPalette brands.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Next-day delivery available for standard primer orders
+3 more records
Product overview1 text field

FASMAC is a Japanese biotech company offering a comprehensive portfolio of contract synthesis, sequencing, and testing services. The core offerings include artificial gene synthesis, DNA/RNA custom synthesis (including primers, modified oligos, and PNA), DNA sequencing (Sanger capillary sequencing), next-generation sequencing (NGS), and genome editing tools (GenomeCraft including CRISPR guide RNA, Cas9, donor DNA). The company also provides specialized analytical services including the proprietary RAISING random integration analysis method, fragment analysis, and genotyping. On the testing side, FASMAC offers food inspection services (GMO testing, allergen testing, microorganism identification), seed/seedling inspection, and plant pathology testing. The company sells reagent kits under the GenCheck brand for DNA extraction and PCR, along with LAMP method products (FLight series), allergen detection kits, and microorganism detection kits. Services are manufactured under ISO9001 quality standards and ISO/IEC 17025 accredited testing laboratory standards.

Product and service8 records
1Artificial Gene Synthesis (人工遺伝子合成)
CategoryContract Synthesis Services
2DNA/RNA Custom Synthesis (DNA/RNA受託合成)
CategoryContract Synthesis Services
3PNA Synthesis (PNA合成)
CategoryContract Synthesis Services
4DNA Sequencing Analysis (DNAシーケンス解析)
CategorySequencing Services
5Next Generation Sequencing Analysis (NGS)
CategorySequencing Services
6Fragment Analysis (フラグメント解析)
CategorySequencing Services
7GenomeCraft Genome Editing Tools (GenomeCraft ゲノム編集ツール)
CategoryGenome Editing Reagents
8RAISING Random Integration Analysis (RAISING)
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Japanese contract research organization providing DNA sequencing, custom synthesis, and molecular biology services to academic and industrial customers in Japan. Highly comparable as a domestic Japan-based molecular biology CRO with overlapping service portfolio and similar customer base.

TypeDirect peer
Description

Korean genomics services company offering DNA sequencing, gene synthesis, oligo synthesis, and molecular biology services across Asia. Comparable in service mix (sequencing, synthesis, genotyping) and Asian market focus, with similar customer segments in academic and biotech research.

TypeBroad incumbent
Description

Global genomics services arm of Eurofins Scientific, offering DNA synthesis, Sanger and NGS sequencing, and genotyping services at industrial scale. Comparable in core service offerings but operates at significantly larger scale with global distribution and broader catalog.

4IDT (Integrated DNA Technologies)
TypeBroad incumbent
Description

Global leader in DNA/RNA oligonucleotide synthesis and genomics services, now part of Danaher. Comparable in custom oligo synthesis and NGS services but operates at much larger scale with global distribution and broader modified-nucleotide catalog.

TypeDirect peer
Description

Chinese genomics company providing DNA sequencing (including the DNB-SEQ platform that FASMAC uses), gene synthesis, and molecular biology services globally. Comparable in sequencing services and Asian market presence, with similar food testing and agricultural genomics offerings.

TypeDirect peer
Description

Global gene synthesis, peptide, and protein services company with strong Asia presence. Comparable in gene synthesis, oligo services, and life science research tools for biotech customers, with overlapping CRISPR-related offerings.

TypeDirect peer
Description

Genomics services company providing Sanger sequencing, NGS, gene synthesis, and molecular biology services to academic and biotech customers. Comparable in core genomics services, customer segments, and turnaround-driven service model.

TypeDirect peer
Description

DNA synthesis company offering custom genes, oligos, and NGS target enrichment at scale using a silicon-based synthesis platform. Comparable in DNA synthesis and gene synthesis services, though at much larger scale and with different underlying synthesis technology.

TypeDirect peer
Description

Japan-based distributor and supplier of molecular biology reagents, enzymes, and instruments to research customers. Comparable as a Japan-headquartered life science tools provider serving the same academic and biotech research customer base.

TypeDirect peer
Description

Specialized food testing laboratory under Eurofins focused on GMO detection, allergen testing, and food authenticity. Directly comparable to FASMAC's food inspection services including GMO and allergen testing, though operating at much larger global scale.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

FASMAC

Biotechnology Contract Servicesfasmac.co.jp

FASMAC is a Japanese biotechnology company providing custom DNA/RNA synthesis, Sanger and next-generation sequencing, CRISPR genome editing tools, and ISO/IEC 17025-accredited food, seed, and plant-pathology testing services to food manufacturers, life science researchers, and seed/agricultural companies primarily in Japan.

What FASMAC does

FASMAC Co., Ltd. (株式会社ファスマック) is a Japanese biotechnology company founded in 2001 and headquartered in Atsugi, Japan, providing contract molecular biology services and food safety testing. The company operates a vertically integrated service platform spanning custom oligonucleotide and gene synthesis, PNA synthesis, Sanger capillary sequencing, next-generation sequencing (via both Illumina and MGI DNB-SEQ platforms), CRISPR/Cas-based genome editing tools, and a proprietary random integration analysis method called RAISING. On the testing side, FASMAC offers food inspection (GMO, allergen, microbial, mycotoxin, and variety identification), seed and seedling testing under ISTA accreditation, plant pathology diagnostics, and veterinary diagnostics, all delivered through an ISO/IEC 17025-accredited testing laboratory operating under an ISO9001-certified quality management system.

FASMAC's technology stack combines in-house developed proprietary assets with licensed IP. The patented RAISING method, co-developed with Japan's National Institute of Infectious Diseases and published in Communications Biology, enables identification of random transgene integration sites with high sensitivity, short turnaround, and lower cost than conventional approaches. The company holds an ERS Genomics-licensed CRISPR/Cas patent portfolio (Patents 6343605 and 6692856) covering Japan and operates the GenomeCraft sub-brand for sgRNA, crRNA/tracrRNA, Cas9 protein, and donor DNA. In-house reagent kit brands include GenCheck (DNA extraction and qPCR reagents), FLight (LAMP isothermal amplification detection), FASPEK (ELISA allergen detection), and AGripalette (plant pathogen detection). Quality and accreditation infrastructure — ISO9001, ISO/IEC 17025, and ISTA — underwrite the regulatory credibility of testing services.

Commercially, FASMAC generates revenue through commissioned service fees (e.g., RAISING Sanger sequencing at 120,000 JPY per 8 samples; NGS at 250,000 JPY per 8 samples), reagent kit sales, and licensing-related distribution. Distribution combines a self-serve web ordering platform (Fasmac Web System) with a regional distributor/agency network across Japanese prefectures. Customers span three primary verticals: food industry companies requiring safety and labeling compliance, life science research institutions and biotech firms needing custom oligos, sequencing, and genome editing tools, and seed and agricultural companies requiring ISTA-certified seed testing and plant pathology diagnostics. The company has a minority-held food testing subsidiary in Qingdao, China, and an affiliated Asia Food Safety Research Center, and has announced a planned facility relocation for spring 2027 or later to support continued expansion. No revenue, funding, or headcount-growth data is publicly disclosed.

FASMAC firmographics

Firmographics
Name
FASMAC
Legal name
株式会社ファスマック
Website
https://fasmac.co.jp
Company type
Private
Founded year
2001
Operating status
Operating
Headcount range
11–50 employees
Short description
FASMAC is a Japanese biotechnology company providing custom DNA/RNA synthesis, Sanger and next-generation sequencing, CRISPR genome editing tools, and ISO/IEC 17025-accredited food, seed, and plant-pathology testing services to food manufacturers, life science researchers, and seed/agricultural companies primarily in Japan.
Ownership category
akta.pro rank

FASMAC industry classification

Industry
Product category
Biotechnology Contract Services
NAICS
Scientific Research and Development Services (5417)
SIC
Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry
Environmental Monitoring Program (EMP) Design & Regulatory Verification (AFALADAI)
akta.pro secondary industries
Genomic Testing & Genetic Evaluation Services (AFAEAJAC), Import/Export Traceability & Trade Compliance Verification (FSMA, EU TRACES) (AFALAGAI)

Keywords

  • DNA sequencing services
  • Oligonucleotide synthesis
  • Food safety testing
  • Genome editing tools
  • GMO detection reagents

Where FASMAC is headquartered

Location

Headquarters

HQ city
Atsugi
HQ country
Japan
HQ region
Asia

Markets served

FASMAC business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goRAISING Sanger Sequencing Plan — 8 samples, 5-10 business days
Unit PricingPay-as-you-goRAISING NGS Plan — 8 samples, 20 business days

Distribution channels4 records

FASMAC product offering

Product offering

Core offering

FASMAC provides custom DNA/RNA and artificial gene synthesis, Sanger and next-generation sequencing, CRISPR/Cas genome editing tools (GenomeCraft), and the proprietary RAISING random integration analysis method. It also runs ISO/IEC 17025 accredited contract testing for food safety (GMO, allergen, microbial, mycotoxin), seed/seedling pathology, and plant disease, and sells proprietary reagent kits under the GenCheck, FLight, FASPEK, and AgriPalette brands.

Product overview

FASMAC is a Japanese biotech company offering a comprehensive portfolio of contract synthesis, sequencing, and testing services. The core offerings include artificial gene synthesis, DNA/RNA custom synthesis (including primers, modified oligos, and PNA), DNA sequencing (Sanger capillary sequencing), next-generation sequencing (NGS), and genome editing tools (GenomeCraft including CRISPR guide RNA, Cas9, donor DNA). The company also provides specialized analytical services including the proprietary RAISING random integration analysis method, fragment analysis, and genotyping. On the testing side, FASMAC offers food inspection services (GMO testing, allergen testing, microorganism identification), seed/seedling inspection, and plant pathology testing. The company sells reagent kits under the GenCheck brand for DNA extraction and PCR, along with LAMP method products (FLight series), allergen detection kits, and microorganism detection kits. Services are manufactured under ISO9001 quality standards and ISO/IEC 17025 accredited testing laboratory standards.

Differentiator

Problem solved

Functional benefit

Brands

  • GenCheck: DNA extraction and PCR kits brand
  • GenomeCraft
  • FLight
  • FASPEK
  • AGripalette

Products and services

  • Artificial Gene Synthesis (人工遺伝子合成)
  • DNA/RNA Custom Synthesis (DNA/RNA受託合成)
  • PNA Synthesis (PNA合成)
  • DNA Sequencing Analysis (DNAシーケンス解析)
  • Next Generation Sequencing Analysis (NGS)
  • Fragment Analysis (フラグメント解析)
  • GenomeCraft Genome Editing Tools (GenomeCraft ゲノム編集ツール)
  • RAISING Random Integration Analysis (RAISING)

Quantifiable outcome

  • Next-day delivery available for standard primer orders
  • +3 more outcomes

Companies that use FASMAC

Customer profile

Segments3 records

Ideal customer profiles3 records

FASMAC technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature8 records

FASMAC partnerships and signals

Strategic signal

Recent moves7 records

Expansion highlights5 records

FASMAC competitors and assessment

Company assessment

Direct peers

  • Hokkaido System Science: Japanese contract research organization providing DNA sequencing, custom synthesis, and molecular biology services to academic and industrial customers in Japan. Highly comparable as a domestic Japan-based molecular biology CRO with overlapping service portfolio and similar customer base.
  • Macrogen: Korean genomics services company offering DNA sequencing, gene synthesis, oligo synthesis, and molecular biology services across Asia. Comparable in service mix (sequencing, synthesis, genotyping) and Asian market focus, with similar customer segments in academic and biotech research.
  • BGI Genomics / MGI Tech: Chinese genomics company providing DNA sequencing (including the DNB-SEQ platform that FASMAC uses), gene synthesis, and molecular biology services globally. Comparable in sequencing services and Asian market presence, with similar food testing and agricultural genomics offerings.
  • GenScript: Global gene synthesis, peptide, and protein services company with strong Asia presence. Comparable in gene synthesis, oligo services, and life science research tools for biotech customers, with overlapping CRISPR-related offerings.
  • Azenta Life Sciences (formerly GeneWiz): Genomics services company providing Sanger sequencing, NGS, gene synthesis, and molecular biology services to academic and biotech customers. Comparable in core genomics services, customer segments, and turnaround-driven service model.
  • Twist Bioscience: DNA synthesis company offering custom genes, oligos, and NGS target enrichment at scale using a silicon-based synthesis platform. Comparable in DNA synthesis and gene synthesis services, though at much larger scale and with different underlying synthesis technology.
  • Nippon Genetics: Japan-based distributor and supplier of molecular biology reagents, enzymes, and instruments to research customers. Comparable as a Japan-headquartered life science tools provider serving the same academic and biotech research customer base.
  • Eurofins GeneScan: Specialized food testing laboratory under Eurofins focused on GMO detection, allergen testing, and food authenticity. Directly comparable to FASMAC's food inspection services including GMO and allergen testing, though operating at much larger global scale.

Broad incumbents

  • Eurofins Genomics: Global genomics services arm of Eurofins Scientific, offering DNA synthesis, Sanger and NGS sequencing, and genotyping services at industrial scale. Comparable in core service offerings but operates at significantly larger scale with global distribution and broader catalog.
  • IDT (Integrated DNA Technologies): Global leader in DNA/RNA oligonucleotide synthesis and genomics services, now part of Danaher. Comparable in custom oligo synthesis and NGS services but operates at much larger scale with global distribution and broader modified-nucleotide catalog.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

FASMAC social profiles

Digital presence

FASMAC compliance and trust

Trust signal

Compliance2 records

FASMAC financial estimates

Financial estimate

Revenue estimate

Valuation estimate

FASMAC leadership team

Management profile

Number of profiles

Profiles2 records

FASMAC subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

FASMAC funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

FASMAC M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about FASMAC

What does FASMAC do?

FASMAC provides custom DNA/RNA and artificial gene synthesis, Sanger and next-generation sequencing, CRISPR/Cas genome editing tools (GenomeCraft), and the proprietary RAISING random integration analysis method. It also runs ISO/IEC 17025 accredited contract testing for food safety (GMO, allergen, microbial, mycotoxin), seed/seedling pathology, and plant disease, and sells proprietary reagent kits under the GenCheck, FLight, FASPEK, and AgriPalette brands.

Is FASMAC a public or private company?

FASMAC is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was FASMAC founded?

FASMAC was founded in 2001. It employs 11 to 50 people.

Where is FASMAC based?

FASMAC is headquartered in Atsugi, Japan, in the Asia region.

Who are FASMAC's main competitors?

Direct peers on record are Hokkaido System Science, Macrogen, BGI Genomics / MGI Tech, GenScript, Azenta Life Sciences (formerly GeneWiz), Twist Bioscience, Nippon Genetics and Eurofins GeneScan. Broad incumbents are Eurofins Genomics and IDT (Integrated DNA Technologies).

Does FASMAC have an API?

No public API is recorded for FASMAC.

What industry is FASMAC in?

FASMAC's product category is Biotechnology Contract Services. Its primary akta.pro industry code is AFALADAI, Environmental Monitoring Program (EMP) Design & Regulatory Verification, with a secondary code of AFAEAJAC, Genomic Testing & Genetic Evaluation Services. Its NAICS code is 5417 and its SIC code is 8734.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales